Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMIOZ29)

Drug Name
Glycine Drug Info
Synonyms
Aciport; Aminoazijnzuur; Aminoessigsaeure; Amitone; Corilin; Glicina; Glicoamin; Gly; Glycin; Glycinum; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Hgly; Leimzucker; Padil; Polyglycine; Acide aminoacetique; Acido aminoacetico; Acidum aminoaceticum; Aminoacetic acid; Aminoethanoic acid; An alpha amino acid ester; Glycine [INN]; Hampshire glycine; Polyglycine II; Sucre de gelatine; Acide aminoacetique [INN-French]; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum [INN-Latin]; GLY (IUPAC abbrev); GLYCINE, ACS; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Gyn-hydralin; L-Glycine; S04-0135; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; GLYCINE 1.5% IN PLASTIC CONTAINER; Glycine (JP15/USP); Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; H-Gly-OH; H2N-CH2-COOH; L-alpha-amino acids; (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid
Indication
Disease Entry ICD 11 Status REF
Allergic rhinitis CA08.0 Approved [1]
Common cold CA00 Approved [1]
Cough MD12 Approved [1]
Cystic fibrosis CA25 Approved [1]
Malnutrition 5B50-5B71 Approved [2]
Rhinitis FA20 Approved [1]
Therapeutic Class
Dietary supplement
Cross-matching ID
PubChem CID
750
ChEBI ID
CHEBI:15428
CAS Number
CAS 56-40-6
TTD Drug ID
DMIOZ29
VARIDT Drug ID
DR00242
INTEDE Drug ID
DR2025

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glutamate receptor ionotropic NMDA 2A (NMDAR2A) TTKJEMQ NMDE1_HUMAN Antagonist [3]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID Highest Status REF
Sodium- and chloride-dependent glycine transporter 1 (SLC6A9) DT2CFQ5 SC6A9_HUMAN Approved [4]
Sodium- and chloride-dependent glycine transporter 2 (SLC6A5) DTE8R17 SC6A5_HUMAN Approved [5]
Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) DTBPTJF S6A12_HUMAN Approved [6]
L-type amino acid transporter 2 (SLC7A8) DTJF3DX LAT2_HUMAN Approved [7]
Alanine/serine/cysteine/threonine transporter 2 (SLC1A5) DTW7AE3 AAAT_HUMAN Approved [8]
Proton-coupled amino acid transporter 1 (SLC36A1) DT48WEM S36A1_HUMAN Approved [9]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID Highest Status REF
Bile acid-CoA thioesterase (BAAT) DERA3OF BAAT_HUMAN Approved [10]
Delta-aminolevulinate synthase 2 (ALAS2) DE437BY HEM0_HUMAN Approved [11]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Glutamate receptor ionotropic NMDA 2A (NMDAR2A) DTT GRIN2A 5 5.446 5.459 3.35
Alanine/serine/cysteine/threonine transporter 2 (SLC1A5) DTP ASCT2 5.096 5.661 6.435 5.113
L-type amino acid transporter 2 (SLC7A8) DTP LAT2 5.741 6.763 7.117 6.583
Sodium- and chloride-dependent glycine transporter 2 (SLC6A5) DTP GLYT2 4.579 6.506 5.89 5.902
Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) DTP BGT1 7.885 6.414 8.53 6.837
Proton-coupled amino acid transporter 1 (SLC36A1) DTP PAT1 3 7.021 5.81 7.907
Sodium- and chloride-dependent glycine transporter 1 (SLC6A9) DTP GLYT1 2.511 3.053 3.087 5.113
Bile acid-CoA thioesterase (BAAT) DME BAAT 8.568 1.585 2.433 1.632
Delta-aminolevulinate synthase 2 (ALAS2) DME ALAS2 2.322 3.018 3.07 2.35
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Allergic rhinitis
ICD Disease Classification CA08.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Glutamate receptor ionotropic NMDA 2A (NMDAR2A) DTT GRIN2A 8.43E-01 -0.37 -0.45
Alanine/serine/cysteine/threonine transporter 2 (SLC1A5) DTP ASCT2 3.77E-01 1.05E-01 3.13E-01
L-type amino acid transporter 2 (SLC7A8) DTP LAT2 7.23E-02 -2.92E-01 -4.31E-01
Sodium- and chloride-dependent glycine transporter 2 (SLC6A5) DTP GLYT2 5.44E-01 -6.94E-02 -3.09E-01
Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) DTP BGT1 2.74E-02 2.41E-01 7.42E-01
Proton-coupled amino acid transporter 1 (SLC36A1) DTP PAT1 2.41E-01 1.14E-01 7.69E-01
Sodium- and chloride-dependent glycine transporter 1 (SLC6A9) DTP GLYT1 6.10E-01 -3.57E-01 -8.09E-01
Bile acid-CoA thioesterase (BAAT) DME BAAT 4.92E-01 -4.16E-02 -1.77E-01
Delta-aminolevulinate synthase 2 (ALAS2) DME ALAS2 9.17E-01 1.28E-01 4.32E-01
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Glycine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 727).
3 Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification. Curr Opin Drug Discov Devel. 2009 Jul;12(4):468-78.
4 Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans. Hum Genet. 2016 Nov;135(11):1263-1268.
5 Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem. 2012 Aug 17;287(34):28975-85.
6 Interpreting metabolomic profiles using unbiased pathway models. PLoS Comput Biol. 2010 Feb 26;6(2):e1000692.
7 The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.3.8.20)
8 Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+). Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1046-53.
9 Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells. Eur J Pharm Sci. 2008 Sep 2;35(1-2):86-95.
10 Bile acid coenzyme A: amino acid N-acyltransferase in the amino acid conjugation of bile acids. Methods Enzymol. 2005;400:374-94.
11 Molecular expression and characterization of erythroid-specific 5-aminolevulinate synthase gain-of-function mutations causing X-linked protoporphyria. Mol Med. 2013 Mar 5;19:18-25.